Van de Velde NV (LON:0IWV)
London flag London · Delayed Price · Currency is GBP · Price in EUR
33.80
0.00 (0.00%)
At close: Jul 30, 2025

Revance Therapeutics Revenue

In the year 2024, Van de Velde NV had annual revenue of 206.44M EUR, down -2.30%. Van de Velde NV had revenue of 90.68M in the half year ending December 31, 2023, a decrease of -7.10%.

Revenue
206.44M EUR
Revenue Growth
-3.93%
P/S Ratio
2.12
Revenue / Employee
261.82K EUR
Employees
788
Market Cap
361.56M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024206.44M-4.86M-2.30%
Dec 31, 2023211.29M-452.00K-0.21%
Dec 31, 2022211.75M16.49M8.45%
Dec 31, 2021195.25M42.91M28.17%
Dec 31, 2020152.34M-43.20M-22.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition